Sunshine Biopharma, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1284205,
    "name": "Sunshine Biopharma, Inc.",
    "stock_name": "Sunshine Biopharma, Inc.",
    "full_name": "Sunshine Biopharma, Inc.",
    "name_url": "stocks-analysis/sunshine-biopharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.44",
    "chg": -0.04,
    "chgp": "-2.7%",
    "dir": -1,
    "prev_price": "1.48",
    "mcapval": "6.42",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US8677814035",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "92.63 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunshine-biopharma-inc-1284205-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Sunshine Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sunshine-biopharma-inc-technically-bullish-or-bearish-3547032",
        "imagepath": "",
        "date": "2025-09-20 19:45:29",
        "description": "As of 29 August 2025, the technical trend for Sunshine Biopharma, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearishness and a monthly Bollinger Bands signal showing mildly bearish conditions. While the MACD and KST are mildly bullish on both weekly and monthly time frames, the overall trend reflects weakness. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -51.0% versus the S&P 500's 12.22%...."
      },
      {
        "title": "Is Sunshine Biopharma, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sunshine-biopharma-inc-overvalued-or-undervalued-3543481",
        "imagepath": "",
        "date": "2025-09-20 18:20:39",
        "description": "As of 9 February 2023, the valuation grade for Sunshine Biopharma, Inc. has moved from does not qualify to risky, indicating increased caution regarding its financial health. The company appears to be overvalued given its significant losses and negative return metrics. Key ratios include a Price to Book Value of 0.30, an EV to EBIT of 0.18, and an EV to EBITDA of 0.19, all of which suggest that the market is not valuing the company favorably compared to its peers.\n\nIn comparison to its peers, Sunshine Biopharma's valuation metrics are less favorable; for instance, Cyclerion Therapeutics, Inc. has an EV to EBITDA of -1.2082, while Blue Water Biotech, Inc. stands at -1.3625. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -51.0% compared to the S&P 500's 12.22%, reinforcing the notion that Sunshine Biopharma is overvalued in the current market context...."
      }
    ],
    "total": 6,
    "sid": "1284205",
    "stock_news_url": "https://www.marketsmojo.com/news/sunshine-biopharma-inc-1284205"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Sunshine Biopharma, Inc. technically bullish or bearish?

2025-09-20 19:45:29

As of 29 August 2025, the technical trend for Sunshine Biopharma, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearishness and a monthly Bollinger Bands signal showing mildly bearish conditions. While the MACD and KST are mildly bullish on both weekly and monthly time frames, the overall trend reflects weakness. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -51.0% versus the S&P 500's 12.22%....

Is Sunshine Biopharma, Inc. overvalued or undervalued?

2025-09-20 18:20:39

As of 9 February 2023, the valuation grade for Sunshine Biopharma, Inc. has moved from does not qualify to risky, indicating increased caution regarding its financial health. The company appears to be overvalued given its significant losses and negative return metrics. Key ratios include a Price to Book Value of 0.30, an EV to EBIT of 0.18, and an EV to EBITDA of 0.19, all of which suggest that the market is not valuing the company favorably compared to its peers. In comparison to its peers, Sunshine Biopharma's valuation metrics are less favorable; for instance, Cyclerion Therapeutics, Inc. has an EV to EBITDA of -1.2082, while Blue Water Biotech, Inc. stands at -1.3625. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -51.0% compared to the S&P 500's 12.22%, reinforcing the notion that Sunshine Biopharma is overvalued in the current market context....

View All News